OBIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.10%

Insider Buying (Last 12 Months): $168,753.60

Insider Selling (Last 12 Months): $8,183.15

Orchestra BioMed Insider Trading History Chart

Orchestra BioMed Share Price & Price History

^$4.68

▼ -0.18 (-3.70%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Orchestra BioMed Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2025	David P Hochman	Insider	Buy	5,000	$4.07	$20,350.00	612,822
9/19/2025	Jason Aryeh	Director	Buy	1,000	$2.45	$2,450.00	108,482
8/25/2025	Andrew Lawrence Taylor	CFO	Buy	2,000	$2.55	$5,100.00	482,788
8/25/2025	Darren Sherman	Insider	Buy	3,000	$2.62	$7,860.00	926,837
8/25/2025	Eric S Fain	Director	Buy	5,760	$2.61	$15,033.60	71,709
8/21/2025	David P Hochman	Insider	Buy	6,000	$2.49	$14,940.00	651,460
8/4/2025	David P Hochman	Insider	Buy	20,000	$2.75	$55,000.00	349,331
6/26/2025	Eric S Fain	Director	Sell	2,683	$3.05	$8,183.15	50,949
12/23/2024	David P Hochman	Insider	Buy	4,000	$4.66	$18,640.00	579,498
12/19/2024	Andrew Lawrence Taylor	CFO	Buy	1,000	$4.83	$4,830.00	344,960
12/18/2024	David P Hochman	Insider	Buy	5,000	$4.91	$24,550.00	575,498
9/24/2024	David P Hochman	Insider	Buy	2,500	$4.91	$12,275.00	570,498
9/9/2024	Darren Sherman	Insider	Sell	6,804	$5.48	$37,285.92	772,691
9/9/2024	Eric S Fain	Director	Sell	1,800	$5.43	$9,774.00	43,010
9/6/2024	Darren Sherman	Insider	Sell	6,819	$5.65	$38,527.35	779,495
9/6/2024	Eric S Fain	Director	Sell	2,000	$5.64	$11,280.00	44,810
9/4/2024	Darren Sherman	Insider	Sell	6,837	$6.10	$41,705.70	793,275
8/14/2024	David P Hochman	Insider	Buy	2,500	$5.84	$14,600.00	567,998
6/25/2024	David P Hochman	Insider	Buy	1,000	$6.95	$6,950.00	333,502
5/30/2024	William Reed Little	Insider	Buy	4,000	$7.00	$28,000.00	307,859

SEC Filings (Institutional Ownership Changes) for Orchestra BioMed (NASDAQ:OBIO)

53.20% of Orchestra BioMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Orchestra BioMed Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Alyeska Investment Group L.P.	1,365,482	$3.39M	0.0%	N/A	2.418%
11/17/2025	Qube Research & Technologies Ltd	25,934	$64K	0.0%	N/A	0.046%
11/17/2025	Millennium Management LLC	373,987	$0.93M	0.0%	-8.7%	0.662%
11/17/2025	Citadel Advisors LLC	54,002	$0.13M	0.0%	+9.2%	0.096%
11/17/2025	Bank of America Corp DE	31,119	$77K	0.0%	+44.2%	0.055%
11/13/2025	Pathstone Holdings LLC	1,006,018	$2.50M	0.0%	N/A	1.782%
11/13/2025	Knott David M Jr	195,000	$0.48M	0.2%	+95.0%	0.345%
11/12/2025	Cresset Asset Management LLC	30,000	$74K	0.0%	N/A	0.053%
11/7/2025	Vanguard Group Inc.	1,481,875	$3.68M	0.0%	+28.0%	3.835%
10/29/2025	AMH Equity Ltd	166,000	$0.41M	0.5%	N/A	0.430%
8/15/2025	Tower Research Capital LLC TRC	27,922	$75K	0.0%	+1,137.7%	0.072%
8/15/2025	Bridgeway Capital Management LLC	25,000	$67K	0.0%	N/A	0.065%
8/15/2025	Bank of America Corp DE	21,577	$58K	0.0%	+35.7%	0.056%
8/14/2025	Jane Street Group LLC	18,513	$50K	0.0%	N/A	0.048%
8/14/2025	The Manufacturers Life Insurance Company	32,518	$87K	0.0%	-22.5%	0.084%
8/14/2025	NewEdge Advisors LLC	44,083	$0.12M	0.0%	N/A	0.114%
8/13/2025	Marshall Wace LLP	49,465	$0.13M	0.0%	N/A	0.128%
8/12/2025	XTX Topco Ltd	16,817	$45K	0.0%	N/A	0.044%
8/12/2025	Catalyst Funds Management Pty Ltd	11,400	$31K	0.0%	N/A	0.030%
8/11/2025	Knott David M Jr	100,000	$0.27M	0.1%	N/A	0.259%
8/8/2025	Creative Planning	15,000	$40K	0.0%	N/A	0.039%
8/8/2025	Geode Capital Management LLC	302,082	$0.81M	0.0%	-49.3%	0.782%
8/1/2025	Y Intercept Hong Kong Ltd	45,447	$0.12M	0.0%	N/A	0.119%
7/24/2025	IFP Advisors Inc	85,358	$0.23M	0.0%	-47.3%	0.223%
6/27/2025	Goldman Sachs Group Inc.	48,729	$0.21M	0.0%	-21.6%	0.127%
5/16/2025	Goldman Sachs Group Inc.	48,729	$0.21M	0.0%	-21.6%	0.127%
5/13/2025	HighTower Advisors LLC	61,000	$0.26M	0.0%	-10.9%	0.159%
5/12/2025	Nuveen LLC	41,729	$0.18M	0.0%	N/A	0.109%
5/9/2025	Deutsche Bank AG	20,219	$87K	0.0%	+67.3%	0.053%
5/5/2025	IFP Advisors Inc	161,921	$0.69M	0.0%	+106.4%	0.423%
2/17/2025	Millennium Management LLC	21,513	$86K	0.0%	N/A	0.057%
2/17/2025	Citadel Advisors LLC	12,279	$49K	0.0%	-39.0%	0.032%
2/17/2025	Bank of America Corp DE	23,780	$95K	0.0%	+42.0%	0.063%
2/14/2025	Boxer Capital Management LLC	238,193	$0.95M	0.1%	N/A	0.627%
2/14/2025	Northern Trust Corp	236,761	$0.95M	0.0%	+2.5%	0.623%
2/14/2025	The Manufacturers Life Insurance Company	37,009	$0.15M	0.0%	+11.1%	0.097%
2/14/2025	Price T Rowe Associates Inc. MD	487,170	$1.95M	0.0%	-5.0%	1.282%
2/13/2025	Barclays PLC	37,786	$0.15M	0.0%	+18.9%	0.099%
2/13/2025	Wells Fargo & Company MN	13,156	$53K	0.0%	+43.6%	0.035%
2/12/2025	Geode Capital Management LLC	572,441	$2.29M	0.0%	+0.9%	1.506%
2/12/2025	JPMorgan Chase & Co.	49,405	$0.20M	0.0%	+354.5%	0.130%
2/7/2025	HighTower Advisors LLC	68,500	$0.27M	0.0%	+34.3%	0.180%
1/17/2025	SG Americas Securities LLC	12,785	$51K	0.0%	+26.0%	0.034%
11/21/2024	SkyView Investment Advisors LLC	12,284	$63K	0.0%	-38.6%	0.032%
11/19/2024	Barclays PLC	31,785	$0.16M	0.0%	+281.3%	0.084%
11/16/2024	Geode Capital Management LLC	567,219	$2.92M	0.0%	+2.0%	1.492%
11/15/2024	Barclays PLC	31,785	$0.16M	0.0%	+281.3%	0.084%
11/15/2024	Jane Street Group LLC	19,070	$98K	0.0%	-19.8%	0.050%
11/15/2024	State Street Corp	429,613	$2.21M	0.0%	+12.4%	1.130%
11/15/2024	RTW Investments LP	8,206,159	$42.18M	0.6%	+46.0%	21.587%
11/13/2024	The Manufacturers Life Insurance Company	33,305	$0.17M	0.0%	-20.9%	0.088%
11/12/2024	Charles Schwab Investment Management Inc.	217,008	$1.12M	0.0%	+3.9%	0.574%
11/1/2024	ABLE Financial Group LLC	13,402	$69K	0.0%	N/A	0.035%
10/3/2024	SG Americas Securities LLC	10,143	$52K	0.0%	N/A	0.028%
8/16/2024	SkyView Investment Advisors LLC	20,000	$0.16M	0.0%	N/A	0.056%
8/15/2024	The Manufacturers Life Insurance Company	42,082	$0.34M	0.0%	+8.4%	0.118%
8/1/2024	Rhumbline Advisers	26,439	$0.22M	0.0%	+192.7%	0.074%
7/26/2024	Bank of New York Mellon Corp	70,682	$0.58M	0.0%	+115.7%	0.197%
5/15/2024	Price T Rowe Associates Inc. MD	571,075	$3.01M	0.0%	-8.3%	1.596%
5/11/2024	Catalytic Wealth RIA LLC	22,261	$0.12M	0.0%	N/A	0.062%
2/1/2024	New York State Common Retirement Fund	3,623	$33K	0.0%	-68.6%	0.010%
10/27/2023	Allspring Global Investments Holdings LLC	4,904	$43K	0.0%	N/A	0.014%
10/27/2023	TD Asset Management Inc	92,678	$0.81M	0.0%	+100.0%	0.259%
10/24/2023	Bank of New York Mellon Corp	40,290	$0.35M	0.0%	+211.2%	0.113%
10/18/2023	UMB Bank n.a.	3,160	$28K	0.0%	N/A	0.009%
10/13/2023	Arkadios Wealth Advisors	51,595	$0.45M	0.0%	N/A	0.144%
8/24/2023	Perceptive Advisors LLC	2,052,868	$14.37M	0.4%	-9.9%	5.744%
8/11/2023	Atika Capital Management LLC	64,651	$0.45M	0.0%	N/A	0.181%
5/16/2023	Boxer Capital LLC	250,000	$4.89M	0.2%	N/A	2.230%
5/15/2023	RTW Investments LP	5,118,507	$100.17M	2.1%	N/A	45.652%
4/18/2023	IFP Advisors Inc	2,980	$34K	0.0%	N/A	0.027%

Data available starting January 2016

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Today's Range

Now: $4.68

$4.57

$4.82

50 Day Range

MA: $3.85

$2.42

$5.35

52 Week Range

Now: $4.68

$2.20

$6.30

Volume

156,365 shs

Average Volume

337,795 shs

Market Capitalization

$264.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Orchestra BioMed?: Orchestra BioMed's top insider investors include:
Darren Sherman (Insider)
David P Hochman (Insider)
Andrew Lawrence Taylor (CFO)
William Reed Little (Insider)
Jason Aryeh (Director)
Eric S Fain (Director)
Learn More about top insider investors at Orchestra BioMed.
Who are the major institutional investors of Orchestra BioMed?: Orchestra BioMed's top institutional investors include:
Vanguard Group Inc. — 3.83%
Alyeska Investment Group L.P. — 2.42%
Pathstone Holdings LLC — 1.78%
Millennium Management LLC — 0.66%
Knott David M Jr — 0.35%
AMH Equity Ltd — 0.43%
Learn More about top institutional investors of Orchestra BioMed stock.
Which major investors are selling Orchestra BioMed stock?: During the previous quarter, OBIO stock was sold by these institutional investors:
Millennium Management LLC
Which major investors are buying Orchestra BioMed stock?: Within the last quarter, OBIO stock was purchased by institutional investors including:
Alyeska Investment Group L.P.
Pathstone Holdings LLC
Vanguard Group Inc.
AMH Equity Ltd
Knott David M Jr
Susquehanna International Group LLP
Cresset Asset Management LLC
Qube Research & Technologies Ltd
In the previous year, these company insiders have bought Orchestra BioMed stock:
Darren Sherman (Insider)
David P Hochman (Insider)
Andrew Lawrence Taylor (CFO)
William Reed Little (Insider)
Jason Aryeh (Director)
Eric S Fain (Director)
Learn More investors buying Orchestra BioMed stock.